Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a de » _ de (Expand Search), a d (Expand Search), i de (Expand Search)
-
1161
-
1162
-
1163
-
1164
-
1165
Fluoxetine decreases the levels of abundant neuropeptides (NPY and CART) in hypothalamic differentiated neuroprogenitor cells.
Published 2014“…<p>Fluoxetine decreases the mRNA levels of neuropeptides that are abundant in differentiated hypothalamic neuroprogenitor cultures NPY (<b>A</b>) and CART (<b>D</b>), but has no effect in the mRNA of AgRP (<b>B</b>) and POMC (<b>C</b>). …”
-
1166
The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged.
Published 2017“…Left, representative traces of responses stimulated with a 20 ms interpulse interval. Scale bar 5 mV, 40 ms. …”
-
1167
-
1168
-
1169
-
1170
-
1171
-
1172
-
1173
-
1174
-
1175
-
1176
-
1177
-
1178
-
1179
-
1180